On this page
Short answer Starting this HIV combination: what to know Common questions Related questions Sources**Abacavir, dolutegravir, and lamivudine are combined to treat HIV infection and help protect your immune system.**
This prescription combination, sold as Triumeq, lowers the amount of HIV in your blood but does not cure HIV. Your clinician checks your treatment history, kidney and liver health, hepatitis B status, and a genetic test for abacavir allergy risk before prescribing it. You take your prescribed dose once daily, with or without food. Taking it consistently and keeping your blood test appointments helps you maintain control of HIV.
Starting this HIV combination: what to know
Common questions
What is Abacavir, Dolutegravir, and Lamivudine used for?
Abacavir, dolutegravir, and lamivudine, combined as Triumeq, treat HIV infection by blocking the virus from multiplying. This lowers HIV levels in your blood and helps protect your immune system, but it does not cure HIV. You take your prescribed dose once daily, with or without food. Before starting, you need a genetic test called HLA-B*5701 to check for increased abacavir allergy risk, plus hepatitis B testing. Your clinician must review your other medicines and kidney and liver health. Do not stop or restart treatment without medical guidance.
